Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

August 10, 2017 - 4:02 p.m.
Gilead Announces U.S. FDA Priority Review Designation for Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for Treatment of HIVPrinter Friendly Version 
August 01, 2017 - 4:02 p.m.
U.S. FDA Approves Expanded Labeling for Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIVPrinter Friendly Version 

Upcoming Events

There are currently no events scheduled.

Most Viewed Links

Updated 08/23/17
1.SEC Filings
2.Annual Reports
3.Earnings
4.Stock Information
5.Fundamentals - Snapshot
* Data collected 08/15/17 - 08/22/17

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$73.34
 Stock is Up 0.74 (1.02%)
Data as of 08/22/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Second Quarter 2017 Gilead Sciences Earnings Conference Call

July 26, 2017 4:30 p.m. ET
Play
Goldman Sachs 38th Annual Global Healthcare Conference

June 15, 2017 10:00 a.m. PT
Play